Ticker brief
CAI CARIS LIFE SCIENCES INC
Consumer, Non-cyclical · Healthcare-Products
last close
$32.00
1 day
+0.9%
14 days
+7.7%
mkt cap
$5.2B
signals 14d
5
authors 14d
4
crowd 14d
-2.1σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| OI alarm | quiet | last alarm 2026-06-16 (z=2.6) |
Sentiment — last 14 days
daily mean sentiment, 2026-10-05 → 2026-10-12 · now +0.10 (−1 bearish … +1 bullish)
Who spoke4
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @NirAoo7 | C | -1.64 | 2 | +0.20 |
| @TheLAPurchaser | A | +0.30 | 1 | -0.70 |
| @AntonLaVay | A | -0.31 | 1 | +0.50 |
| @fj_nextstage | C | -2.23 | 1 | +0.10 |
Recent signals5of 5 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-12 | @fj_nextstage | +0.10 | Lists IBD50 additions and deletions with technical reasons, favoring CRM's 50-day-line bounce. | +7.8% | tweet ↗ |
| 2026-10-09 | @NirAoo7 | +0.20 | Screens liquid Stage 2/2A stocks with DCR above 80% and gains exceeding 4%. | +7.7% | tweet ↗ |
| 2026-10-06 | @AntonLaVay | +0.50 | Presents TEM, NTRA and CAI as beneficiaries of downstream AI-biotech bottlenecks. | +16.6% | tweet ↗ |
| 2026-10-05 | @NirAoo7 | +0.20 | Screen lists liquid Stage 2/2A stocks up over 4% with daily close-range above 80%. | +5.3% | tweet ↗ |
| 2026-10-05 | @TheLAPurchaser | -0.70 | Strongly condemns speculative behavior across the named genomics stocks. | +5.3% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.